VCRE
Vicore Pharma Holding AB
9.30$
-1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | -96.5% | |
| – | – | – | -96.5% | |
| – | +10.5% | -9.8% | +56.6% | |
| – | +18.8% | +13.1% | +34.6% | |
| – | +11.6% | -6.6% | +52.9% | |
| – | – | – | – | |
| – | -75.0% | +300.0% | +650.0% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.